Chris Gunter is senior adviser to the director of the U.S. National Human Genome Research Institute in Bethesda, Maryland.
Chris Gunter
Associate Professor
Emory University
From this contributor
Call to update standards for publishing autism research
Autism researchers should take steps to communicate their findings before, during and after publication of the paper.
Call to update standards for publishing autism research
By
Chris Gunter
1 December 2015 | 4 min read
Communication lapses hinder autism research
The term ‘deficit model’ traditionally means treating people with autism by focusing on their limitations rather than their strengths. Chris Gunter introduces the deficit model in a different context: science communication.
Great sequencing power — great responsibility
Chris Gunter and Daniel MacArthur discuss guidelines for assessing the evidence that a genetic variant causes autism or another disorder.
Great sequencing power — great responsibility
By
Chris Gunter, Daniel MacArthur
6 June 2014 | 4 min read
Explore more from The Transmitter
Neuro’s ark: Understanding fast foraging with star-nosed moles
“MacArthur genius” Kenneth Catania outlined the physiology behind the moles’ stellar foraging skills two decades ago. Next, he wants to better characterize their food-seeking behavior.
Neuro’s ark: Understanding fast foraging with star-nosed moles
“MacArthur genius” Kenneth Catania outlined the physiology behind the moles’ stellar foraging skills two decades ago. Next, he wants to better characterize their food-seeking behavior.
By
Lauren Schneider
4 February 2026 | 7 min read
Largest leucovorin-autism trial retracted
A reanalysis of the data revealed errors and failed to replicate the results.
Largest leucovorin-autism trial retracted
A reanalysis of the data revealed errors and failed to replicate the results.
By
Claudia López Lloreda
3 February 2026 | 4 min read
NIH scraps policy that classified basic research in people as clinical trials
The policy aimed to increase the transparency of research in humans but created “a bureaucratic nightmare” for basic neuroscientists.
NIH scraps policy that classified basic research in people as clinical trials
The policy aimed to increase the transparency of research in humans but created “a bureaucratic nightmare” for basic neuroscientists.
By
Calli McMurray
3 February 2026 | 5 min read